Trial document
DRKS00020764
Trial Description
Title
Userfriendliness and usability of the Dfree ultrasonic sensor to support participation and autonomy of people with detrusor hypotonia: a mixed-method study.
Trial Acronym
Dfree
URL of the Trial
[---]*
Brief Summary in Lay Language
Study to evaluate an increase in quality of life and participation in everyday life by using a Japanese ultrasonic sensor, the Dfree. The device promises to solve incontinence problems in everyday life and thus to enable participation.
Brief Summary in Scientific Language
The ultrasound device Dfree is a technical artifact for predicting the need for micturition, to support people having difficulties in controlling micturition. The Dfree sensor is recommended as a new social assistive care technology for accompanying therapy by urinary incontinence. At the moment, however, it is still unclear whether the Dfree offers advantages over previously established therapeutic approaches. The building blocks of conservative therapy for urinary bladder incontinence include, for example, drinking and micturition training, physiotherapy, electrostimulation and drug intervention therapies with cholinergics or alpha blockers or therapy using bladder pacemakers (Bump et al. 1991; Füsgen 2005; Klingler 2007, p. 10; ders., 2014 ; Borello-France et al. 2013; Huang et al. 2019). In addition, the supply of catheter systems in the sense of long-term catheterization as well as operative therapies for bladder emptying disorders and urinary incontinence (Eberhardt and Geissbühler 2000, 44 f .; Jost 2014) are relevant. The Dfree has the potential to minimize problems resulting from urinary incontinence in an uncomplicated and simple manner. However, there is currently no evidence of user-friendliness and usability. In particular, actually there are no studies available to assess the applicability of the Dfree ultrasound device in older people with urinary incontinence, or studies to change or improve the quality of life and improved ability to participate in everyday life. This needs to be evaluated.
Do you plan to share individual participant data with other researchers?
No
Description IPD sharing plan:
[---]*
Organizational Data
- DRKS00020764
- 2020/02/05
- [---]*
- yes
- Approved
- 2019-133, Ethikkommission der Medizinischen Fakultät der Martin-Luther-Universität Halle Wittenberg
Secondary IDs
- [---]*
Health Condition or Problem studied
- N31.1 - Reflex neuropathic bladder, not elsewhere classified
- N31.2 - Flaccid neuropathic bladder, not elsewhere classified
Interventions/Observational Groups
- 30 patients with detrusor hypotension use the Dfree ultrasound sensor 12hours/day during a period of 3 month. At the measurement times T0 (before intervention begins) and T1 (after completion of the intervention period) they will be asked about their OoL using the questionnaire KHQ. In addition, satisfaction with the treatment was assessed by the ZUF-8 questionnaire and supported by a guided interview.
Characteristics
- Interventional
- [---]*
- Single arm study
- Open (masking not used)
- [---]*
- Uncontrolled/Single arm
- Treatment
- Single (group)
- N/A
- N/A
Primary Outcome
The primary target parameter is the perceived change in the subjectively recognized QoL for the urinary incontinence symptom caused by detrusor hypotonia while using the Dfree sensor. The change in the average scores is considered. The KHQ is helpful to determine the detailed status of the QoL of older men and women [...] who suffer from urinary bladder incontinence (Okamura et al. 2002, p. 411). The KHQ was selected to determine the primary target parameter because it guarantees a comprehensive and valid assessment of micturition satisfaction.
Secondary Outcome
Another secondary target parameter is the number of successful toilet visits without involuntary urination.
The following endpoints are also taken into account as secondary target parameters:
• Reported therapy adherence
• Functional status
• Self-reporting degree of autonomy
• Subjectively perceived improvement in the quality of care
The effect of using the Dfree sensor is observed over time until the end of the observation period or application of another therapeutic intervention.
Countries of Recruitment
- Germany
Locations of Recruitment
- University Medical Center
Recruitment
- Actual
- 2020/06/25
- 30
- Monocenter trial
- National
Inclusion Criteria
- Both, male and female
- 18 Years
- no maximum age
Additional Inclusion Criteria
• Age ≥18 years
• incontinence
• Urologically confirmed detrusor hypotonia
• Significant suffering
Exclusion Criteria
• existing urinary tract infection
• bladder- catheter
• Detrusorhypertonus
• Difficult micturition
• haematuria
• dementia
• Immobility (min. 50 m walking distance).
• Inability to get up from a sitting position
• Life expectancy less than 3 months
Addresses
-
start of 1:1-Block address primary-sponsor
- MLU Halle-Wittenberg, Med. Fak.; DELH; FORMAT-Projekt
- Mr. M.A. Sebastian Hofstetter
- Magdeburger Str. 12
- 06112 Halle (Saale)
- Germany
end of 1:1-Block address primary-sponsorstart of 1:1-Block address contact primary-sponsor- 0345 557 4064
- [---]*
- sebastian.hofstetter at medizin.uni-halle.de
- https://format.medizin.uni-halle.de/sebastian/
end of 1:1-Block address contact primary-sponsor -
start of 1:1-Block address other
- Universitätsklinikum Halle, Klinik und Poliklinik für Urologie
- Ms. Dr. med. Sandra Schönburg
- Ernst-Grube-Str. 40
- 06120 Halle (Saale)
- Germany
end of 1:1-Block address otherstart of 1:1-Block address contact other- 0345-557-1862
- [---]*
- sandra.schoenburg at uk-halle.de
- https://www.medizin.uni-halle.de/index.php?id=5268
end of 1:1-Block address contact other -
start of 1:1-Block address scientific-contact
- MLU Halle-Wittenberg, Med. Fak.; DELH; FORMAT-Projekt
- Mr. M.A. Sebastian Hofstetter
- Magdeburger Str. 12
- 06112 Halle (Saale)
- Germany
end of 1:1-Block address scientific-contactstart of 1:1-Block address contact scientific-contact- 0345 557 4064
- [---]*
- sebastian.hofstetter at medizin.uni-halle.de
- https://format.medizin.uni-halle.de/sebastian/
end of 1:1-Block address contact scientific-contact -
start of 1:1-Block address public-contact
- MLU Halle-Wittenberg, Med. Fak.; DELH; FORMAT-Projekt
- Mr. M.A. Sebastian Hofstetter
- Magdeburger Str. 12
- 06112 Halle (Saale)
- Germany
end of 1:1-Block address public-contactstart of 1:1-Block address contact public-contact- 0345 557 4064
- [---]*
- sebastian.hofstetter at medizin.uni-halle.de
- https://format.medizin.uni-halle.de/sebastian/
end of 1:1-Block address contact public-contact
Sources of Monetary or Material Support
-
start of 1:1-Block address materialSupport
- MLU Halle-Wittenberg, Med. Fak.; DELH; FORMAT-Projekt
- Mr. M.A. Sebastian Hofstetter
- Magdeburger Str. 12
- 06112 Halle (Saale)
- Germany
end of 1:1-Block address materialSupportstart of 1:1-Block address contact materialSupport- 0345 557 4064
- [---]*
- sebastian.hofstetter at medizin.uni-halle.de
- https://format.medizin.uni-halle.de/sebastian/
end of 1:1-Block address contact materialSupport
Status
- Recruiting ongoing
- [---]*
Trial Publications, Results and other Documents
- [---]*